NT5E and neoplasm: Treatment of tumour cells with paclitaxel, carboplatin, doxorubicin, or gemcitabine resulted in induction of PD-L1 and CD73 expression, providing a strong rationale for combining chemotherapy with anti-PD-L1 and anti-CD73 antibodies [25].